Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Discovery of Microbiome-based Biomarkers for Patients With Cancer Using Metagenomic

NCT04567446 is registered in ClinicalTrials.gov with Gustave Roussy, Cancer Campus, Grand Paris as lead sponsor.

NCT NCT04567446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04567446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Discovery of Microbiome-based Biomarkers for Patients With Cancer Using Metagenomic
Lead sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Phase
Observational
Overall status
Unknown status
Start date
January 22, 2018
Completion date
December 31, 2024
Enrollment
1,100 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

cancer